The Glasgow Royal Infirmary is a large teaching hospital. With a capacity of around 1,000 beds, the hospital campus covers an area of around 8 hectares, and straddles the Townhead and Dennistoun districts on the north-eastern fringe of the city centre of Glasgow, Scotland.

There are 1,077 beds in Glasgow Royal Infirmary | Haematology.

During the past decade, Glasgow Royal Infirmary | Haematology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Glasgow Royal Infirmary | Haematology" are "Hot Flashes" (2 trials), "Vasomotor Symptoms Associated With Menopause" (1 trials) and "Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer" (1 trials). Many other conditions were trialed in "Glasgow Royal Infirmary | Haematology" in a lesser frequency.

Most popular intervention types in "Glasgow Royal Infirmary | Haematology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Elinzanetant (BAY3427080)" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Glasgow Royal Infirmary | Haematology" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Glasgow Royal Infirmary | Haematology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Glasgow Royal Infirmary | Haematology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Glasgow Royal Infirmary | Haematology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".